BioCanRx: Biotherapeutics for Cancer Treatment
BioCanRx: Biotherapeutics for Cancer Treatment — based in Ottawa, ON, CA — founded 2014. Holds 9 federal grants ($76.1M CAD) on record in Canadian open government data.
Details
Federal Grants
9| Program | Title | Organization | Value | Period |
|---|---|---|---|---|
| $38,009,500 | Mar 31, 2024 — Mar 30, 2029 | |||
| $38,009,500 | Mar 31, 2024 — Mar 30, 2029 | |||
| $5,636 | Apr 25, 2021 — Feb 25, 2022 | |||
| $5,563 | Apr 20, 2025 — Aug 29, 2025 | |||
| $5,354 | Apr 21, 2024 — Aug 30, 2024 | |||
| $5,012 | Apr 23, 2023 — Sep 1, 2023 | |||
| $4,840 | Apr 24, 2022 — Sep 2, 2022 | |||
| $4,430 | May 5, 2019 — Aug 31, 2019 | |||
| $3,360 | Apr 29, 2018 — Aug 31, 2018 |
Browse related
Frequently asked questions
What federal funding has BioCanRx: Biotherapeutics for Cancer Treatment received?
BioCanRx: Biotherapeutics for Cancer Treatment has 9 federal grants ($76.1M CAD) and 0 federal procurement contracts ($0 CAD) on record in Canadian open government data.
Contains information licensed under the Open Government Licence – Canada.
Adapted from Statistics Canada, Open Database of Businesses, 2024. This does not constitute an endorsement by Statistics Canada of this product. (Statistics Canada Open Licence)
Contains data licensed by His Majesty the King in right of Canada, as represented by the Minister of Industry, the minister responsible for the administration of the Canadian Intellectual Property Office. (CIPO Terms)
OSFI data reproduced from the Office of the Superintendent of Financial Institutions. (Terms)
FINTRAC MSB registry data reproduced from FINTRAC. (Terms)
Registraire des entreprises. « Registre des entreprises du Québec », Données Québec. Licensed under CC BY 4.0.
Contains information licensed under the Open Government Licence – Toronto, Open Government Licence – Vancouver, Open Government Licence – Calgary, and Open Government Licence – Edmonton.